Yersinia enterocolitica leads to transient induction of TNF-alpha and activates NF-κB in synovial fibroblasts

Clinical and Experimental Rheumatology

Volumn 22, Issue 3, 2004, Pages 278-284

  Meyer Bahlburg, Almut ^a,c   Greil, Sabine ^a,d   Kruse, Niels ^a,d   Marienfeld, Ralf ^a,e   Serfling, Edgar ^a,e   Huppertz, Hans Iko ^a,b,e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d Institute VIRION SERION GmbH   (Germany)

^e KLINIKUM BREMEN MITTE   (Germany)

Author keywords

NF B; Pathogenesis; Reactive arthritis; Salmonella enteritidis; TNF ; Yersinia enterocolitica

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE COURSE; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTIVE ARTHRITIS; SALMONELLA ENTERITIDIS; SYNOVIOCYTE; WESTERN BLOTTING; YERSINIA ENTEROCOLITICA;

EID: 2342619591     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. GRANFORS K, JALKANEN S, von ESSEN R et al.: Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320: 216-21.
2. GRANFORS K, JALKANEN S, LINDBERG AA et al.: Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990; 336: 685-8.
3. TAYLOR-ROBINSON D, GILROY CB, THOMAS BJ, KEAT AC: Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 1992; 340: 81-2.
4. BAS S, GRIFFAIS R, KVIEN TK, GLENNAS A, MELBY K, VISCHER TL: Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995; 38: 1005-13.
5. HUPPERTZ HI, HEESEMANN J: Experimental Yersinia infection of human synovial cells: Persistence of live bacteria and generation of bacterial antigen deposits including "ghosts", nucleic acid-free bacterial rods. Infect Immun 1996; 64: 1484-7.
6. HUPPERTZ HI, HEESEMANN J: Invasion and persistence of Salmonella in human fibroblasts positive or negative for endogenous HLA B27. Ann Rheum Dis 1997; 56: 671-6.
7. MEYER-BAHLBURG A, BRINKHOFF J, KRENN V, TREBESIUS K, HEESEMANN J, HUPPERTZ HI: Infection of synovial fibroblasts in culture by Yersinia enterocolitica and Salmonella enterica serovar enteritidis: ultrastructural investigation with respect to the pathogenesis of reactive arthritis. Infect Immun 2001; 69: 7915-21.
8. YANG X, GABUZDA D: Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol 1999 73: 3460-6.
9. BOHN E, AUTHENRIETH IB: IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-γ production in NK cells and CD4+ T cells. J Immunol 1996; 156: 1458-68.
10. HUPPERTZ HI, HEESEMANN J: Effect of cytokines on invasion and survival of Yersinia in primary human fibroblasts. Med Microbiol Immunol 1999; 187: 157-164.
11. SIEPER J, BRAUN J, KINGSLEY GH: Report on the fourth international workshop on reactive arthritis. Arthritis Rheum 2000; 43: 720-34.
12. BRAUN J, YIN Z, SÜPILLER I et al.: Low secretion of tumor necrosis factor α, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 1999; 42: 2039-44.
13. COLLART MA, BAUERLE P, VASSALLI P: Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF kappa B. Mol Cell Biol 1990; 10: 1498-506.
14. SHAKHOV AN, COLLART MA, VASSALLI P, NEDOSPASOV SA, JONGENEEL CV: Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 1990; 171: 36-47.
15. SIEBENLIST U, FRANZOSO G, BROWN K: Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994: 10: 405-55.
16. THANOS D, MANIATIS T: NF-κB : A lesson in family values. Cell 1995; 180: 529-32.
17. NEURATH MF, FUSS I, SCHURMANN G et al.: Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann NY Acad Sci 1998; 17: 149-59.
18. SCHMID RM, ADLER G: NF-κB, Rel/Iκ Implications in gastrointestinal diseases. Gastroenterology 2000; 118: 1208-28.
19. FIRESTEIN GS, MANNING AM: Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum 1999; 42: 609-21.
20. CAMPBELL IK, GERONDAKIS S, O'DONNELL K, WICKS IP: Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest 2000; 105: 1799-806.
21. MAROK R, WINYARD PG, COUMBE A et al.: Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue. Arthritis Rheum 1999; 39: 583-91.
22. CHRISTMAN JW, SADIKOT RT, BLACKWELL TS: The role of nuclear factor-κB in pulmonary diseases. Chest 2000; 117: 1482-7.
23. LENTSCH AB, WARD PA: The NFkappa B/ IkappaB system in acute inflammation. Arch Immunol Ther Exp 2000; 48: 59-63.
24. HUPPERTZ HI, CHANTLER FK: Restricted mumps virus infection of cells derived from normal human joint tissue. J Gen Virol 1991; 72: 339-47.
25. FUJISAWA K, AONO H, HASUNUMA Z, YAMAMOTO K, MITA S, NISHIOKA K: Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor α. Arthritis Rheum 1996; 39: 197-203.
26. KRUSE N, MORIABADI NF, TOYKA KV, RIECKMANN P: Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells. J Immunol Methods 2001; 247: 131-9.
27. KRUSE N, GREIF M, MORIABADI NF, MARX L, TOYKA KV, RIECKMANN P: Variations in cytokine mRNA expression during normal human pregnancy. Clin Exp Immunol 2000; 119: 317-22.
28. SCHREIBER E, MATTHIAS P, MÜLLER MM, SCHAFFNER W: Rapid detection of octamer binding proteins with "mini-extracts" prepared from small numbers of cells. Nucleic Acids Res 1989; 17: 6419.
29. BRADFORD MM: A rapid and sensitive method for the quantitation of micrograms quantities of protein using the principle of protein-dye binding. Annu Biochem 1976; 42: 248-54.
30. BRIEGEL K, HENTSCH B, PFEUFFER I, SERFLING E: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter. Nucl Acids Res 1991; 12: 5929-36.
31. PENTTINEN MA, HOLMBERG CI, SISTONEN L, GRANFORS K: HLA-B27 modulates nuclear factor kB activation in human monocytic cels exposed to lippolysaccharide. Arthritis Rheum 2002; 46: 2172-80
32. BAEUERLE PA, HENKEL T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-79.
33. BALDWIN Jr AS: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 274: 782-4.
34. LI P, SNAZ I, O'KEEFE RJ, SCHWARZ EM: NF-κB regulates VCAM-1 expression on fibroblast-like synoviocytes. J Immunol 2000; 164: 5990-7.